Valore202020212022202320242025TTMSpese di vendita, generali e amministrative3.67 B3.53 B3.44 B3.5 B3.7 B3.97 B3.97 BRicerca e sviluppo997 M967 M98 M953 M998 M1.01 B1.01 BReddito operativo-3.57 B1.72 B-2.1 B433 M-303 M2.16 B2.16 BProventi non operativi, Totale-834 M-1.06 B-966 M-1.06 B-981 M-934 M-934 MOneri finanziari, al netto degli interessi capitalizzati963 M891 M930 M1.03 B1 B916 M—Proventi non operativi, esclusi gli oneri finanziari-1.8 B-1.95 B-1.9 B-2.09 B-1.98 B-1.85 B-934 MEntrate/uscite straordinarie———————Utile al lordo delle imposte-4.27 B667 M-3.04 B-622 M-1.28 B1.24 B1.24 BQuota di utile138 M9 M21 M2 M1 M15 M15 MImposte-168 M211 M-638 M-7 M676 M-180 M-180 MInteressi di minoranza-109 M39 M-53 M-56 M-320 M7 M7 MAltri proventi/oneri al netto delle imposte———————Utile netto al lordo delle attività cessate-3.99 B417 M-2.35 B-559 M-1.92 B1.41 B1.41 BAttività cessate————281 M00Utile netto-3.99 B417 M-2.35 B-559 M-1.64 B1.41 B1.41 BRegolazione della diluizione———————Dividendi privilegiati———————Utile netto diluito attribuibile agli azionisti ordinari-3.99 B417 M-2.35 B-559 M-1.64 B1.41 B1.41 BUtile base per azione (EPS base)-3.640.38-2.12-0.5-1.451.231.23Utile diluito per azione (EPS diluito)-3.640.38-2.12-0.5-1.451.211.21Numero medio di azioni ordinarie in circolazione1.09 B1.1 B1.11 B1.12 B1.13 B1.15 B4.58 BAzioni diluite in circolazione1.09 B1.11 B1.11 B1.12 B1.13 B1.16 B4.65 BEBITDA-824 M5.06 B2.52 B4.59 B3.31 B5.33 B2.57 BEBIT-2.38 B3.73 B1.21 B3.44 B2.25 B4.33 B1.99 BCosto del fatturato8.93 B8.28 B7.95 B8.2 B8.48 B8.32 B8.32 BAltri costi del venduto——4.2 B————Ammortamento e svalutazione (liquidità)1.56 B1.33 B1.31 B1.15 B1.06 B1 B581 M
Teva Pharmaceutical Industries Limited American Depositary Shar
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform.
Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States.
Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America.
Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 26th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs.